Prostate Cancer - Results from #3020

Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial. March 24, 2023

Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer. March 24, 2023

Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer. March 24, 2023

Systematic or targeted fusion-guided biopsy. March 23, 2023

A pair of deep learning auto-contouring models for prostate cancer patients injected with a radio-transparent versus radiopaque hydrogel spacer. March 23, 2023

Integrating radium-223 therapy into the management of metastatic prostate cancer care: a plain language summary. March 23, 2023

Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease. March 23, 2023

Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? March 23, 2023

Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs. March 23, 2023

Palette Life Sciences Announces Transaction with Global Healthcare Investor OrbiMed March 22, 2023

Understanding the sexual health perceptions, concerns, and needs of female partners of prostate cancer survivors. March 22, 2023

Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study). March 22, 2023

Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer. March 22, 2023

First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report. March 22, 2023

Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study. March 22, 2023

Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT. March 22, 2023

Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions. March 22, 2023

RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis. March 22, 2023

Value Based Payment Shift for Independent Urology Practices: Roadmap and Barriers March 21, 2023

Artera Launches with $90 Million in Funding to Personalize Cancer Therapy with Multimodal AI March 21, 2023

Page 152 of 1439